Medication info

Jeil Lidocaine Injection

Prescription medicationIntravenous injection
Ingredient · strength
Lidocaine Hydrochloride Hydrate›21.33mg / 1mL
Manufacturer / importer
Cheil Pharmaceutical Co., Ltd.
Appearance
This product is a colorless, transparent injection solution in a colorless vial.
Packaging
10 vials/box [20 milliliters/vial * 10]
Approval status
Active

MFDS item code 197900151 · Notified 1979.08.10 · Insurance code 650500341

Summary

Main use
Anesthesia (epidural, nerve block, infiltration, etc.); treatment of ventricular arrhythmias
Who receives it
Adults
Adult administration
[Anesthesia] Adults 1. Epidural anesthesia (maximum recommended dose: 200㎎ per dose as lidocaine hydrochloride hydrate): 200㎎ 2. Conduction anesthesia (maximum recommended dose: 200㎎ per dose as lidocaine hydrochloride hydrate): 40-200㎎; 60-120㎎ for nerve block 3. Infiltration anesthesia (maximum recommended dose: 200㎎ per dose as lidocaine hydrochloride hydrate): 40-200㎎ 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose as appropriate according to age, anesthetized area, site, tissue, symptoms, constitution, and general condition. [Medical use] Adults 1. Single intravenous dose: Slowly inject 50-100㎎ (1-2㎎/㎏) as lidocaine hydrochloride hydrate intravenously over 1-2 minutes. If no effect is observed, administer the same dose after 5 minutes. If continued effect is desired, the same dose may also be administered at 10-20-minute intervals; however, the maximum recommended dose within 1 hour is 300㎎. 2. Intravenous infusion: If a single intravenous dose is effective and a sustained effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject intravenously at a rate of 1-2㎎ per minute as lidocaine hydrochloride hydrate. The infusion rate may be increased if necessary, but the maximum rate is 4㎎ per minute.

Ingredients

Manufacturer
Cheil Pharmaceutical Co., Ltd.

Efficacy & effects

Anesthesia (epidural, nerve block, infiltration, etc.); treatment of ventricular arrhythmias

  • Ventricular arrhythmia
View approved original text

This medicine is used for various methods of anesthesia including epidural anesthesia, nerve block anesthesia, infiltration anesthesia, and surface anesthesia. Additionally, it is used in internal medicine for the treatment of ventricular arrhythmias.

How it is given

Adult administration

[Anesthesia] Adults 1. Epidural anesthesia (maximum recommended dose: 200㎎ per dose as lidocaine hydrochloride hydrate): 200㎎ 2. Conduction anesthesia (maximum recommended dose: 200㎎ per dose as lidocaine hydrochloride hydrate): 40-200㎎; 60-120㎎ for nerve block 3. Infiltration anesthesia (maximum recommended dose: 200㎎ per dose as lidocaine hydrochloride hydrate): 40-200㎎ 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose as appropriate according to age, anesthetized area, site, tissue, symptoms, constitution, and general condition. [Medical use] Adults 1. Single intravenous dose: Slowly inject 50-100㎎ (1-2㎎/㎏) as lidocaine hydrochloride hydrate intravenously over 1-2 minutes. If no effect is observed, administer the same dose after 5 minutes. If continued effect is desired, the same dose may also be administered at 10-20-minute intervals; however, the maximum recommended dose within 1 hour is 300㎎. 2. Intravenous infusion: If a single intravenous dose is effective and a sustained effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject intravenously at a rate of 1-2㎎ per minute as lidocaine hydrochloride hydrate. The infusion rate may be increased if necessary, but the maximum rate is 4㎎ per minute.

Precautions

This medication should not be used in patients who are undergoing epidural anesthesia if there is significant bleeding or if they are in shock. It should also not be administered to patients with inflammation at the injection site or in the surrounding area, or those with sepsis. Moreover, patients who are allergic to this drug or other amide-type local anesthetics should not use it. Caution should be exercised when using this drug in patients with central nervous system diseases, pregnant women, elderly patients, patients with severe hypertension, or those with severe spinal deformities. When using this drug, close observation of the patient's condition is necessary as shock or serious side effects may occur. If symptoms such as a drop in blood pressure, facial pallor, abnormal pulse, or respiratory depression appear, administration should be stopped immediately, and appropriate treatment should be provided. Malignant hyperthermia may occur during drug administration, characterized by a sudden rise in body temperature, muscle rigidity, changes in blood color, hyperventilation, sweating, acidosis, hyperkalemia, and red urine. If these symptoms appear, administration should be discontinued immediately and specialized treatment sought. Serious symptoms such as tremors or convulsions in the central nervous system may occur, prompting the cessation of the drug and initiation of appropriate pharmacotherapy if symptoms present. Drowsiness, anxiety, dizziness, nausea, and vomiting may also occur, requiring careful monitoring. Allergic reactions such as skin rashes or swelling may occur, and any unusual symptoms should be reported immediately. Caution is necessary when using this drug with vasoconstrictors, and it is advisable not to add vasoconstrictors particularly for patients with hypertension or cardiovascular disease. For women who are pregnant or may become pregnant, the safety of this medication has not been established; hence, it should only be used when the benefits of treatment outweigh the risks. Elderly patients may experience stronger effects from this drug, thus dose adjustments should be made, and their condition should be closely monitored. This drug is not for ophthalmic use. Metabolites of this drug have been reported to potentially cause mutations in animal studies, so it is important not to use it at high concentrations for prolonged periods. When used for internal medicine, it should not be administered to patients with severe cardiac conduction disorders or those sensitive to this medication. Careful administration is required for patients with weak cardiac function, severely impaired liver or kidney function, reduced blood volume, those in shock, and elderly patients. Avoid overdose, and maintain continuous monitoring of blood pressure and electrocardiograms during administration. There may be interactions with other medications, so if there are concomitant medications, it is essential to inform healthcare professionals.

Side effects

Shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a sealed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 and 30 degrees Celsius, as this preserves the efficacy and safety of the drug for a longer period.

Appearance and packaging

Appearance

This product is a colorless, transparent injection solution in a colorless vial.

Package unit

10 vials/box [20 milliliters/vial * 10]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.